Close Menu

NEW YORK (GenomeWeb) – Scandinavian private equity firm Summa Equity said today that it has acquired Swedish life science firm Olink Proteomics.

According to the companies, Summa plans through the acquisition to help Olink scale its business globally. Based out of Uppsala, Sweden, Olink also maintains a US office and laboratory in Watertown, Massachusetts.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.